The time for actively recommending the screening of asymptomatic men has passed
There is little doubt that Australian doctors order too many prostate‐specific antigen (PSA) screening tests. The analysis by Franco and colleagues of electronic data for 142 000 Victorian general practice patients, published in this issue of the MJA, found that 46% of men aged 70–74 years had had at least two PSA tests during the preceding two years,1 despite Australian guidelines recommending against PSA screening of asymptomatic men in this age group.2 Indeed, the Royal Australian College of General Practitioners (RACGP) does not recommend PSA screening of most asymptomatic men of any age.3 Some testing might be justified (for example, screening of men at high risk, or prostate disease monitoring), but when Australian general practitioner registrars were asked to record specific reasons for ordering PSA tests, “asymptomatic screening” accounted for three‐quarters of requests.4
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Franco GS, Hardie RA, Li L, et al. Prostate‐specific antigen testing of asymptomatic men in Australia: an observational study based on electronic general practice data. Med J Aust 2021; 215: 228–229.
- 2. Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel. PSA testing and early management of test‐detected prostate cancer. Jan 2016. https://wiki.cancer.org.au/australiawiki/images/1/1b/PSA_Testing_and_Early_Management_of_Test‐detected_Prostate_Cancer_‐_Clinical_practice_guidelines_‐_Nov15.pdf (viewed June 2021).
- 3. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 9th edition. Melbourne: RACGP, 2016. https://www.racgp.org.au/download/Documents/Guidelines/Redbook9/17048‐Red‐Book‐9th‐Edition.pdf (viewed June 2021).
- 4. Magin P, Tapley A, Davey A, et al. Prevalence and associations of general practitioners’ ordering of “non‐symptomatic” prostate‐specific antigen tests: a cross‐sectional analysis. Int J Clin Pract 2017; 71: e12998.
- 5. Lowe A, Bennett M, Badenoch S. Research, awareness, support: ten years of progress in prostate cancer. 2012 community attitudes survey. Sydney: Prostate Cancer Foundation of Australia, 2012. https://www.prostate.org.au/media/238805/2012_cas_report_online.pdf (viewed June 2021).
- 6. Pickles K, Carter SM, Rychetnik L, Entwistle VA. Doctors’ perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study. BMJ Open 2016; 6: e011932.
- 7. Movember. We believe that every man has the right to know if he has prostate cancer, and that he deserves the right to treat it rather than suffer from a late‐stage diagnosis. Movember, 13 Oct 2011. https://us.movember.com/story/view/id/2234/movember‐s‐position‐on‐the‐psa‐test (viewed June 2021).
- 8. Urological Society of Australia and New Zealand. Urological Society of Australia and New Zealand PSA testing policy 2009. http://www.urologysa.com.au/pdf/usanz‐2009‐psa‐testing‐policy‐final1.pdf (viewed June 2021).
- 9. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate‐specific antigen (PSA) test: a systematic review and meta‐analysis. BMJ 2018; 362: k3519.
- 10. Royal Australian College of General Practitioners. Should I have prostate cancer screening? Aug 2015. https://www.racgp.org.au/download/Documents/Guidelines/prostate‐cancer‐screening‐infosheetpdf.pdf (viewed June 2021).
No relevant disclosures.